149 related articles for article (PubMed ID: 37734964)
1. Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection.
Morena D; Lumbreras S; Rodríguez JM; Campos C; Castillo M; Benavent M; Izquierdo JL
Arch Bronconeumol; 2023 Dec; 59(12):797-804. PubMed ID: 37734964
[TBL] [Abstract][Full Text] [Related]
2. Obstructive sleep apnea increases the risk of herpes zoster and postherpetic neuralgia.
Wang CA; Hsieh WC; Hsu TJ; Tsai FJ; Hsu CY
Postgrad Med; 2024 Jan; 136(1):22-29. PubMed ID: 38011906
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Safonova E; Yawn BP; Welte T; Wang C
Respir Res; 2023 Jan; 24(1):35. PubMed ID: 36709298
[TBL] [Abstract][Full Text] [Related]
4. Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older.
Muñoz-Quiles C; López-Lacort M; Orrico-Sánchez A; Díez-Domingo J
J Infect; 2018 Aug; 77(2):131-136. PubMed ID: 29742472
[TBL] [Abstract][Full Text] [Related]
5. A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan.
Yaegashi M; Matsui H; Yoshida A; Ban H; Miyazaki R; Oda N; Hattori K; Motomura Y; Usami H; Matsushita H
Vaccine; 2024 Jan; 42(3):464-470. PubMed ID: 38172019
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease is associated with an increased risk of herpes zoster: A retrospective United States claims database analysis.
Thompson-Leduc P; Ghaswalla P; Cheng WY; Wang MJ; Bogart M; Patterson BJ; Duh MS; Park S; Yawn BP
Clin Respir J; 2022 Dec; 16(12):826-834. PubMed ID: 36415956
[TBL] [Abstract][Full Text] [Related]
7. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.
Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E
J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228
[TBL] [Abstract][Full Text] [Related]
8. Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study.
Mbinta JF; Wang AX; Nguyen BP; Paynter J; Awuni PMA; Pine R; Sporle AA; Simpson CR
Lancet Reg Health West Pac; 2023 Feb; 31():100601. PubMed ID: 36879782
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against Herpes Zoster and Postherpetic Neuralgia.
Oxman MN; Levin MJ;
J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S228-36. PubMed ID: 18419402
[TBL] [Abstract][Full Text] [Related]
10. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
11. Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster.
Park SY; Kim JY; Kwon JS; Jeon NY; Kim MC; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Med Virol; 2019 Nov; 91(11):1995-2000. PubMed ID: 31286531
[TBL] [Abstract][Full Text] [Related]
12. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia.
Peng Q; Guo X; Luo Y; Wang G; Zhong L; Zhu J; Li Y; Zeng X; Feng Z
Front Immunol; 2022; 13():887892. PubMed ID: 35720399
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Risk Factors for Postherpetic Neuralgia in Patients With Postmalignancy Herpes Zoster.
Li HL; Gong G; Wang JL; Li FB
Pain Physician; 2023 Jul; 26(4):E397-E403. PubMed ID: 37535787
[TBL] [Abstract][Full Text] [Related]
15. Increasing incidence associated with herpes zoster infection in British Columbia, Canada.
Marra F; Chong M; Najafzadeh M
BMC Infect Dis; 2016 Oct; 16(1):589. PubMed ID: 27765026
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster and postherpetic neuralgia in Catalonia (Spain).
Salleras L; Salleras M; Salvador P; Soldevila N; Prat A; Garrido P; Domínguez A
Hum Vaccin Immunother; 2015; 11(1):178-84. PubMed ID: 25483532
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster and postherpetic neuralgia in older adults.
Schmader K
Clin Geriatr Med; 2007 Aug; 23(3):615-32, vii-viii. PubMed ID: 17631237
[TBL] [Abstract][Full Text] [Related]
18. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data.
Klompas M; Kulldorff M; Vilk Y; Bialek SR; Harpaz R
Mayo Clin Proc; 2011 Dec; 86(12):1146-53. PubMed ID: 21997577
[TBL] [Abstract][Full Text] [Related]
19. Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.
Thompson RR; Kong CL; Porco TC; Kim E; Ebert CD; Acharya NR
Clin Infect Dis; 2021 Nov; 73(9):e3210-e3217. PubMed ID: 32829399
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
Liesegang TJ
Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
